Abramson Cancer Center At Penn Medicine

This early-stage study is testing if a combination of targeted radiation and an oral antibiotic is safe and feasible to give before a patient's own immune cells are engineered to fight their cancer (CAR-T therapy). It is for adults with aggressive B-cell lymphomas that have come …

This study is testing whether injecting an experimental treatment called RP2 directly into stomach or esophagus tumors, along with standard chemotherapy (FLOT), is safe and works better than chemotherapy alone before surgery. Researchers want to see if this combination kills more…

This study is testing a new strategy for people with advanced kidney cancer. After initial drug treatment works to shrink or control the cancer, doctors will use targeted procedures like surgery or radiation to remove all visible tumors. The main goal is to see if patients can th…

This study aims to validate a new test called SpotitEarly that uses trained dogs and artificial intelligence to detect breast cancer from a person's breath. Researchers will enroll 500 women who are either scheduled for routine breast cancer screening or a breast biopsy. The accu…

This study is testing whether a shorter, 5-day course of radiation therapy is safe for children and young adults with incurable brain cancers. The goal is to see if this approach reduces treatment burden while still helping control symptoms and maintain quality of life. Researche…

This study is testing a mobile phone app designed to help women taking hormone therapy for early-stage breast cancer. The app helps them track and manage treatment side effects, with the goal of helping them stay on their medication as recommended. Researchers will enroll 60 wome…